Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;59(7):977-979.
doi: 10.1007/s00592-022-01862-7. Epub 2022 Mar 1.

Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown

M Mateu-Salat  1 , Q Asla  1 , A Chico  1   2   3 , M C Martínez  1 , M J Martínez  1 , A López  1 , I Pujol  1 , R Corcoy  4   5   6
Affiliations

Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown

M Mateu-Salat et al. Acta Diabetol. 2022 Jul.
No abstract available

Keywords: COVID19; Lockdown; Pregnancy; Times in range; Type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

M.M.S. has received funds from Novo Nordisk for speaker engagements. A.C. has received funds from Abbott, Lilly, Novo Nordisk, Sanofi, Menarini, Roche Diagnostics, Medtronic, Diabeloop, and Novalab as a consultant for speaker engagements or travel grants. R.C. has received funds from Abbott, Ascensia, Lilly, Medtronic, Menarini, Novo Nordisk, and Sanofi as a consultant for speaker engagements or travel grants.

Figures

Fig. 1
Fig. 1
Glucometrics for pregnant women with type 1 diabetes before and during lockdown in the first wave of COVID19 pandemics
See this image and copyright information in PMC

References

    1. Mesa A, Viñals C, Pueyo I, et al. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020;167:108354. doi: 10.1016/j.diabres.2020.108354. - DOI - PMC - PubMed
    1. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593–1603. doi: 10.2337/DCI19-0028. - DOI - PMC - PubMed
    1. Nagi D, Wilmot E, Owen K, et al. ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic. Br J Diabetes. 2021;21(1):123–131. doi: 10.15277/BJD.2021.282. - DOI
    1. Tundidor D, Meek CL, Yamamoto J, et al. Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2021 doi: 10.1089/dia.2021.0073. - DOI - PMC - PubMed
    1. Jovanovic L, Peterson CM, Saxena BB, Dawood MY, Saudek CD. Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women. Am J Med. 1980;68(1):105–112. doi: 10.1016/0002-9343(80)90179-5. - DOI - PubMed